- Home
- GLOB vs BRKR Comparison
GLOB vs BRKR Comparison
Compare GLOB & BRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GLOB | BRKR |
|---|---|---|
| Founded | 2003 | 1960 |
| Country | Luxembourg | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Laboratory Analytical Instruments |
| Sector | Technology | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.7B | 7.0B |
| IPO Year | 2014 | 2000 |
Fundamental Metrics
Financial Performance| Metric | GLOB | BRKR |
|---|---|---|
| Price | $68.35 | $48.22 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 13 |
| Target Price | ★ $95.71 | $49.42 |
| AVG Volume (30 Days) | 1.1M | ★ 2.1M |
| Earning Date | 11-13-2025 | 02-12-2026 |
| Dividend Yield | N/A | ★ 0.42% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.19 | N/A |
| Revenue | $2,484,891,000.00 | ★ $3,438,900,000.00 |
| Revenue This Year | $3.37 | $3.55 |
| Revenue Next Year | $1.92 | $1.49 |
| P/E Ratio | $31.02 | ★ N/A |
| Revenue Growth | 5.56 | ★ 6.10 |
| 52 Week Low | $54.36 | $28.53 |
| 52 Week High | $228.98 | $64.64 |
Technical Indicators
Market Signals| Indicator | GLOB | BRKR |
|---|---|---|
| Relative Strength Index (RSI) | 56.39 | 60.92 |
| Support Level | $66.10 | $44.11 |
| Resistance Level | $70.56 | $49.15 |
| Average True Range (ATR) | 2.59 | 1.76 |
| MACD | -0.25 | -0.08 |
| Stochastic Oscillator | 36.46 | 79.57 |
Price Performance
Historical ComparisonAbout GLOB Globant S.A.
Globant is a next-generation IT services company that primarily assists clients with their digital transformation efforts by creating customized software for them. The company was founded in 2003 in Argentina but is currently headquartered in Luxembourg and primarily serves clients in the US and Latin America. Globant's client base is relatively concentrated in the media and entertainment and financial services industries.
About BRKR Bruker Corporation
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.